Prognostic stratification in early-stage hepatocellular carcinoma: Imaging biomarkers are needed

被引：1
作者：
Dana, Jeremy [1 ,2 ,3 ,4 ]
Sutter, Olivier [5 ,6 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Diagnost Radiol, Montreal, PQ, Canada
[2] McGill Univ, Hlth Ctr, Res Inst, Augmented Intelligence & Precis Hlth Lab AIPHL, Montreal, PQ, Canada
[3] Univ Strasbourg, Inst Hosp Univ IHU Strasbourg, Strasbourg, France
[4] Univ Strasbourg, Inst Rech Malad Virales & Hepat, Inserm, U1110, Strasbourg, France
[5] Hop Univ Paris Seine St Denis, Hop Avicenne, APHP, Intervent Radiol Unit, Bobigny, France
[6] Univ Bordeaux, Team MONC, Inria, CNRS,UMR 5251,Bordeaux INP, Bordeaux, France
来源：
LIVER INTERNATIONAL | 2024年 / 44卷 / 04期
关键词：
D O I：
10.1111/liv.15869
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：881 / 883
页数：3
相关论文
共 7 条
[1]   Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients [J].
Doyle, Adam ;
Gorgen, Andre ;
Muaddi, Hala ;
Aravinthan, Aloysious D. ;
Issachar, Assaf ;
Mironov, Oleg ;
Zhang, Wei ;
Kachura, John ;
Beecroft, Robert ;
Cleary, Sean P. ;
Ghanekar, Anand ;
Greig, Paul D. ;
McGilvray, Ian D. ;
Selzner, Markus ;
Cattral, Mark S. ;
Grant, David R. ;
Lilly, Leslie B. ;
Selzner, Nazia ;
Renner, Eberhard L. ;
Sherman, Morris ;
Sapisochin, Gonzalo .
JOURNAL OF HEPATOLOGY, 2019, 70 (05) :866-873
[2]   No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm [J].
Mohkam, Kayvan ;
Dumont, Paul-Noel ;
Manichon, Anne-Frederique ;
Jouvet, Jean-Christophe ;
Boussel, Loic ;
Merle, Philippe ;
Ducerf, Christian ;
Lesurtel, Mickael ;
Rode, Agnes ;
Mabrut, Jean-Yves .
JOURNAL OF HEPATOLOGY, 2018, 68 (06) :1172-1180
[3]   Optimizing curative management of hepatocellular carcinoma [J].
Nahon, Pierre ;
Vibert, Eric ;
Nault, Jean-Charles ;
Ganne-Carrie, Nathalie ;
Ziol, Marianne ;
Seror, Olivier .
LIVER INTERNATIONAL, 2020, 40 :109-115
[4]   Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3trial [J].
Qin, Shukui ;
Chen, Minshan ;
Cheng, Ann-Lii ;
Kaseb, Ahmed ;
Kudo, Masatoshi ;
Lee, Han Chu ;
Yopp, Adam C. ;
Zhou, Jian ;
Wang, Lu ;
Wen, Xiaoyu ;
Heo, Jeong ;
Tak, Won Young ;
Nakamura, Shinichiro ;
Numata, Kazushi ;
Uguen, Thomas ;
Hsiehchen, David ;
Cha, Edward ;
Hack, Stephen P. ;
Lian, Qinshu ;
Ma, Ning ;
Spahn, Jessica H. ;
Wang, Yulei ;
Wu, Chun ;
Chow, Pierce K. H. .
LANCET, 2023, 402 (10415) :1835-1847
[5]   BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update [J].
Reig, Maria ;
Forner, Alejandro ;
Rimola, Jordi ;
Ferrer-Fabrega, Joana ;
Burrel, Marta ;
Garcia-Criado, Angeles ;
Kelley, Robin K. ;
Galle, Peter R. ;
Mazzaferro, Vincenzo ;
Salem, Riad ;
Sangro, Bruno ;
Singal, Amit G. ;
Vogel, Arndt ;
Fuster, Josep ;
Ayuso, Carmen ;
Bruix, Jordi .
JOURNAL OF HEPATOLOGY, 2022, 76 (03) :681-693
[6]   Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trail) [J].
Takayama, Tadatoshi ;
Hasegawa, Kiyoshi ;
Izumi, Namiki ;
Kudo, Masatoshi ;
Shimada, Mitsuo ;
Yamanaka, Naoki ;
Inomata, Masafumi ;
Kaneko, Shuichi ;
Nakayama, Hisashi ;
Kawaguchi, Yoshikuni ;
Kashiwabara, Kosuke ;
Tateishi, Ryosuke ;
Shiina, Shuichiro ;
Koike, Kazuhiko ;
Matsuyama, Yutaka ;
Omata, Masao ;
Makuuchi, Masatoshi ;
Kokudo, Norihiro .
LIVER CANCER, 2022, 11 (03) :209-218
[7]   A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation [J].
Wang, Wentao ;
Wang, Yueyue ;
Song, Danjun ;
Zhou, Yingting ;
Luo, Rongkui ;
Ying, Siqi ;
Yang, Li ;
Sun, Wei ;
Cai, Jiabin ;
Wang, Xi ;
Bao, Zhen ;
Zheng, Jiaping ;
Zeng, Mengsu ;
Gao, Qiang ;
Wang, Xiaoying ;
Zhou, Jian ;
Wang, Manning ;
Shao, Guoliang ;
Rao, Sheng-xiang ;
Zhu, Kai .
LIVER INTERNATIONAL, 2024, 44 (04) :894-906
1